Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7838]

Bladder tumours reduced by 90% using nanorobots

Bladder tumours reduced by 90% using nanorobots

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 stage III-IVA cervical cancer

FDA approves pembrolizumab with chemoradiotherapy for FIGO 2014 stage III-IVA cervical cancer

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma

Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Novel approach for lymph node metastasis treatment

Novel approach for lymph node metastasis treatment

Research shows deadly brain cancer can mimic healthy neurons

Research shows deadly brain cancer can mimic healthy neurons

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in patients with breast cancer

Researchers find Boswellia, an extract of frankincense, shows anti-cancer activity in patients with breast cancer

Researchers discover compound that fights leukaemia, lymphoma

Researchers discover compound that fights leukaemia, lymphoma

One more step towards treatment of PARP inhibitor-resistant ovarian cancers

One more step towards treatment of PARP inhibitor-resistant ovarian cancers

European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line treatment of patients with EGFR-mutated NSCLC

European Medicines Agency is looking at approving lazertinib, in combination with amivantamab, for the first-line...

More from ecancer